Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

LECO Partners with the Joint Mass Spectrometry Centre

Published: Wednesday, August 22, 2012
Last Updated: Wednesday, August 22, 2012
Bookmark and Share
The LECO European Life Sciences and Chemical Analysis Centre is providing access to high resolution mass spectrometry instrumentation to the Joint Mass Spectrometry Centre.

The centre is a cooperative partnership between the University of Rostock and the Helmholtz Zentrum München – German Research Center for Environmental Health.

The Joint Mass Spectrometry Centre will utilize the LECO Citius™ LC-HRT (High Resolution TOFMS) and Pegasus® GC-HRT for applied research in areas such as health-relevant environmental analysis, comprehensive molecular profiling, biomedical and forensic research, and analytical method development. Designed for complex sample analysis, LECO’s HRT instrumentation provides acquisition speeds of up to 200 spectra/second, mass resolution up to 100,000 FWHM, and mass accuracy less than 1 ppm.

The Joint Mass Spectrometry Centre is led by Prof. Dr. Ralf Zimmermann, who also serves as both the chair of analytical chemistry at the University of Rostock and the head of the comprehensive molecular analytics cooperation group at the Helmholtz Zentrum München.

“LECO is honored to support the work of Prof. Dr. Zimmermann and the Joint Mass Spectrometry Centre characterizing complex molecular mixtures,” said Jürgen Wendt, LCMS Technical Product Specialist, LECO European Life Science and Chemical Analysis Centre. “We are confident that his team will significantly benefit from the advantages provided by High Resolution TOFMS.”

The teams at both the Joint Mass Spectrometry Centre and LECO have high expectations for the partnership.

“For the past 10 years at the Helmholtz Zentrum München, we have worked very successfully with GCxGC-TOFMS technology,” said Prof. Dr. Ralf Zimmermann. “In the framework of our most recent cooperation, we are now very much looking forward to new, exciting applications with the novel LECO fast high resolution TOF systems, the GC-HRT and LC-HRT. The new HRT technology platform is perfectly suited for our complex molecular characterisation applications in the field of energy and fuels, environmental research, and metabolomics.”

“My expectation is novel applications of cutting-edge technology,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science. “The experience and creativity of Dr. Zimmermann and his team will allow the LECO HRT platform to be highlighted and fully utilized to solve meaningful problems in environmental science, metabolomics, and more. Speaking with Dr. Zimmermann and the scientists at Helmholtz, I’m excited about the possibilities, and I think other scientists will be just as excited about the outcomes.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

LECO Announces Special Events at ASMS
Company to host a series of events during the conference held at the America’s Center, Saint Louis, MO on May 31-June 4.
Tuesday, May 12, 2015
Metabolomics Symposium Scheduled for November 4 in Dallas
Event is sponsored by LECO, AB SCIEX, GERSTEL and UT Southwestern Medical Center.
Tuesday, October 22, 2013
LECO Supports New West Coast Metabolomics Center
The West Coast Metabolomics Center will receive access to the LECO Citius™ LC-HRT.
Monday, September 16, 2013
LECO Announces Special Events at ASMS
Special events at the 61st ASMS Conference on Mass Spectrometry and Allied Topics, June 9-13 in Minneapolis.
Thursday, June 06, 2013
AB SCIEX and LECO Announces Co-marketing Agreement
Bundled solutions leverage the synergy between two technology leaders.
Wednesday, March 20, 2013
LECO and Genedata Collaborate on Mass Spectrometry Data Analysis
Efficient mass spectrometry data analysis capabilities now available to a broad range of pharmaceutical, industrial biotech, and life science companies.
Thursday, September 27, 2012
LECO Corporation Opens New Separation Science R&D Facility
Newest addition of Michigan-the Elizabeth S. Warren Technical Centre.
Tuesday, June 05, 2012
LECO Opens Global Support Center
The new building will house its Service, Customer Training, and Consumables departments, as well as three mobile laboratories.
Wednesday, January 11, 2006
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos